* treatment with chlorpromazine (cpz) the month preceding the inclusion visit * contraindication to the cpz: * hypersensitivity to the active substance or any of the excipients * risk of glaucoma by closing the angle. * risk of urinary retention linked to urethroprostatic disorders. * history of agranulocytosis * association with dopaminergic outside parkinson's (cabergoline, quinagolide), citalopram, escitalopram, domperidone, hydroxyzine, and piperaquine * wheat allergy * risk of qt prolongation and occurrence of severe ventricular rhythm disorders: the existence of bradycardia, hypokalaemia, long congenital or acquired qt * history of ischemic stroke * treatment with chloroquine or hydroxychloroquine during the inclusion visit or the previous month * need for mechanical ventilation linked to covid-19, during the inclusion visit or the last month * in the opinion of the clinical team, imminent progression to death within the next 24 hours regardless of treatment * psychiatric care under duress * protected adults, persons under the protection of justice * pregnant or lactating woman

* treatment with chlorpromazine (cpz) the month preceding the inclusion visit * contraindication to the cpz: * hypersensitivity to the active substance or any of the excipients * risk of glaucoma by closing the angle. * risk of urinary retention linked to urethroprostatic disorders. * history of agranulocytosis * association with dopaminergic outside parkinson's (cabergoline, quinagolide), citalopram, escitalopram, domperidone, hydroxyzine, and piperaquine * wheat allergy * risk of qt prolongation and occurrence of severe ventricular rhythm disorders: the existence of bradycardia, hypokalaemia, long congenital or acquired qt * history of ischemic stroke * treatment with chloroquine or hydroxychloroquine during the inclusion visit or the previous month * need for mechanical ventilation linked to covid-19, during the inclusion visit or the last month * in the opinion of the clinical team, imminent progression to death within the next 24 hours regardless of treatment * psychiatric care under duress * protected adults, persons under the protection of justice * pregnant or lactating woman

- treatment with chlorpromazine (cpz) the month preceding the inclusion visit - contraindication to the cpz: - hypersensitivity to the active substance or any of the excipients - risk of glaucoma by closing the angle. - risk of urinary retention linked to urethroprostatic disorders. - history of agranulocytosis - association with dopaminergic outside parkinson's (cabergoline, quinagolide), citalopram, escitalopram, domperidone, hydroxyzine, and piperaquine - wheat allergy - risk of qt prolongation and occurrence of severe ventricular rhythm disorders: the existence of bradycardia, hypokalaemia, long congenital or acquired qt - history of ischemic stroke - treatment with chloroquine or hydroxychloroquine during the inclusion visit or the previous month - need for mechanical ventilation linked to covid-19, during the inclusion visit or the last month - in the opinion of the clinical team, imminent progression to death within the next 24 hours regardless of treatment - psychiatric care under duress - protected adults, persons under the protection of justice - pregnant or lactating woman

- treatment with chlorpromazine (cpz) the month preceding the inclusion visit - contraindication to the cpz: - hypersensitivity to the active substance or any of the excipients - risk of glaucoma by closing the angle. - risk of urinary retention linked to urethroprostatic disorders. - history of agranulocytosis - association with dopaminergic outside parkinson's (cabergoline, quinagolide), citalopram, escitalopram, domperidone, hydroxyzine, and piperaquine - wheat allergy - risk of qt prolongation and occurrence of severe ventricular rhythm disorders: the existence of bradycardia, hypokalaemia, long congenital or acquired qt - history of ischemic stroke - treatment with chloroquine or hydroxychloroquine during the inclusion visit or the previous month - need for mechanical ventilation linked to covid-19, during the inclusion visit or the last month - in the opinion of the clinical team, imminent progression to death within the next 24 hours regardless of treatment - psychiatric care under duress - protected adults, persons under the protection of justice - pregnant or lactating woman